Detalhe da pesquisa
1.
Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
J Infect Dis
; 225(12): 2208-2218, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865071
2.
Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
Am J Obstet Gynecol
; 227(6): 871.e1-871.e7, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569516
3.
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder.
Eur J Contracept Reprod Health Care
; 27(6): 478-485, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062524
4.
Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
Am J Obstet Gynecol
; 222(4S): S888.e1-S888.e6, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31866516
5.
A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
AIDS Behav
; 24(2): 607-616, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877580
6.
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
Clin Infect Dis
; 68(7): 1136-1143, 2019 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289435
7.
Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
Clin Infect Dis
; 68(7): 1144-1151, 2019 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289485
8.
Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART.
J Antimicrob Chemother
; 74(10): 3003-3010, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299074
9.
Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].
Am J Obstet Gynecol
; 229(3): 358, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495438
10.
Investigating Pregnancy Outcomes After Abnormal Cell-Free DNA Test Results.
J Genet Couns
; 27(4): 902-908, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368276
11.
Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.
Clin Infect Dis
; 62(3): 375-382, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508513
12.
Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.
AIDS Behav
; 20(11): 2644-2653, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26837628
13.
Changes in genital tract immune cell populations after initiation of intrauterine contraception.
Am J Obstet Gynecol
; 211(5): 489.e1-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24834865
14.
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
J Int AIDS Soc
; 27(3): e26223, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444118
15.
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
PLoS One
; 19(6): e0304552, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838028
16.
Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.
AIDS Behav
; 17(2): 737-47, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065145
17.
Early pregnancy confirmation availability at crisis pregnancy centers and abortion facilities in the United States.
Contraception
; 117: 30-35, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084711
18.
Dextromethorphan as a novel nonopioid adjunctive agent for pain control with medication abortion: A randomized controlled trial.
Contraception
; 118: 109908, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332661
19.
Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
Obstet Gynecol
; 141(5): 1004-1006, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023451
20.
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability.
Front Reprod Health
; 5: 1147628, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37484873